Creatine Shows Promise for Depression but Evidence Remains Mixed
A new review of 5 clinical trials finds creatine may boost mood in some women with depression, but results are inconsistent across groups.
122 articles in this topic
A new review of 5 clinical trials finds creatine may boost mood in some women with depression, but results are inconsistent across groups.
UCLA researchers found long-term chlorpyrifos exposure more than doubles Parkinson's risk and damages dopamine neurons directly.
A landmark study of 463,000 teens found cannabis use doubles the risk of psychotic and bipolar disorders by young adulthood.
A modified B12 molecule delivers nitric oxide directly to glioblastoma tumors and boosts existing treatments in animal and lab studies.
Johns Hopkins scientists found brainstem neurons that filter distractions in mice, offering new clues to treating ADHD and attention disorders.
High-dose niacin revived suppressed immune cells in glioblastoma patients, with 82% showing no progression at 6 months — 28% better than expected.
Baylor scientists find tubulin redirects rogue brain proteins away from toxic aggregates, pointing to a novel neurodegenerative disease strategy.
A molecule called OLE restores microglia's protective function, reducing amyloid plaques and improving memory in animal models.
UC Riverside researchers show amyloid beta may displace tau from neurons, triggering brain cell breakdown before plaques even form.
The SenNet atlas reveals where aging cells accumulate in human tissues, opening new doors for senolytic therapies and healthspan extension.
Early-life exposure to DEHP, a plasticizer in everyday products, caused lasting anxiety in male rats — and GABA or testosterone reversed it.
A 12-week clinical trial found older adults taking probiotics with antidepressants had greater reductions in depression and anxiety than placebo.